, Volume 26, Issue 5, pp 298–300 | Cite as

Relative frequency of Lyme borreliosis and of its clinical manifestations in Europe

  • M. A. Cimmino
  • European community Concerted Action on Risk Assessment in Lyme Borreliosis
Clinical and Epidemiological Studies Originalia


To survey the frequency of Lyme borreliosis (LB) and to evaluate its clinical presentation in Europe, we performed a questionnaire interview of a sample of physicians involved in the care of patients with LB. Reference laboratories in 15 European countries agreed to participate by distributing questionnaires to those clinicians who most frequently requested LB serology for their patients. The mean number of cases of LB per physician per country showed a longitudinal geographical gradient, with a higher number of patients seen in Eastern and Central Europe than in Western Europe. Skin involvement was seen in 58.9% of the patients, neurological involvement in 34.3%, joint involvement in 15.4% and cardiac involvement in 2%. About 30% of the patients had multisystem involvement. The frequency of the different manifestations varied greatly between countries. The frequency of diagnosis of LB and the number of serological tests requested were inversely correlated.


Serological Test Cardiac Involvement Joint Involvement Borrelia Burgdorferi Neurological Involvement 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Berglund, J., Eitrem, R., Ornstein, K., Lindberg, A., Ringnér, Å., Elmrud, H., Carlsson, M., Runehagen, A., Svanborg, C., Norrby, R.: An epidemiological study of Lyme disease in Southern Sweden. N. Engl. J. Med. 333 (1995) 1319–1324.PubMedCrossRefGoogle Scholar
  2. 2.
    Cimmino, M. A., Fumarola, D., Sambri, V., Accardo, S.: The epidemiology of Lyme borreliosis in Italy. Microbiologica 15 (1992) 419–424.PubMedGoogle Scholar
  3. 3.
    Stanek, G., O'Connell, S., Cimmino, M. A., Aberer, E., Kristoferitsch, W., Gränstrom, M., Guy, E., Gray, J.: European Union Concerted Action on Risk Assessment in Lyme borreliosis: clinical case definition for Lyme borreliosis. Wien Klin: Wochenschr. 108 (1996) 741–747.Google Scholar
  4. 4.
    Baranton, G., Postic, D., Saint Girons, I., Boerlin, P., Piffaretti, J. C., Assous, M. V., Grimont, P. A. D.: Delineation ofBorrelia burgdorferi sensu stricto, Borrelia garinii sp. nov. and group VS461 associated with Lyme borreliosis. Int. J. Syst. Bacteriol. 42 (1992) 378–383.PubMedCrossRefGoogle Scholar
  5. 5.
    Golightly, M. G.: Laboratory considerations in the diagnosis and management of Lyme borreliosis. Am. J. Clin. Pathol. 99 (1992) 168–174.Google Scholar

Copyright information

© MMV Medizin Verlag GmbH München 1998

Authors and Affiliations

  • M. A. Cimmino
    • 1
  • European community Concerted Action on Risk Assessment in Lyme Borreliosis
  1. 1.Rheumatology Unit, Dept. of Internal MedicineUniversity of GenovaGenovaItaly

Personalised recommendations